Meaux Cedex, France Clinical Trials

A listing of Meaux Cedex, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 14 clinical trials
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients

The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025. The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.

Grand H pital de l'Est Francilien - Site de Marne-la-Vall e
 (10.2 away) Contact site
  • 24 May, 2021
  • +3 other locations
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

Comparison of survival in patients with or without a matched donor at 36 months

blood transfusion
cell transplantation
GHEF, site de Meaux
 (0.9 away) Contact site
  • 26 Jan, 2021
  • +65 other locations
Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis

NutriPEPA2 is a randomized, single-blind, prospective, multicenter trial, in two parallel arms to confirm that the adsorbent PEPA membrane may decrease mortality related to inflammation and malnutrition encountered in HD or HDF-treated stage 5 renal failure compared to a non-adsorbent synthetic membrane.

chronic haemodialysis
renal failure
chronic hemodialysis
chronic renal insufficiency
Aura Paris Plaisance
 (26.9 away) Contact site
  • 23 Jan, 2021
  • +10 other locations
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.

monoclonal protein
monoclonal antibodies
bone marrow plasma cells
multiple myeloma
Centre Hospitalier d'Argenteuil Victor Dupouy
 (29.0 away) Contact site
  • 29 Mar, 2021
  • +37 other locations
Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome

Myelodysplastic syndromes (MDS) are heterogeneous malignant bone marrow disorders characterized by ineffective haematopoiesis, peripheral blood cytopenias and variable risk of leukaemia transformation. Anemia is the most common manifestation of bone marrow failure in MDS. After failure with first-line treatment by Erythropoietin, patients survive in average 5 years under long term …

Saint-Louis Hospital, APHP
 (25.2 away) Contact site
  • 17 Mar, 2021
  • +17 other locations
National Cohort of Children Born to HIV-positive Mothers

The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

Centre Hospitalier de Lagny
 (9.8 away) Contact site
  • 08 May, 2021
  • +51 other locations
Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma

A Vater's ampulloma is a rare digestive tumour which accounts for under 1% of all digestive tumours. The only curative treatment is complete excision (surgical or endoscopic) of the lesions which is possible in 80% of cases , with or without adjuvant treatment. The reference radical treatment is cephalic duodenopancreatectomy …

Le Kremlin Bicetre
 (26.1 away) Contact site
  • 26 Jan, 2021
  • +30 other locations
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

This is a non-interventional observational study aimed at understanding the real world effectiveness of novel agents used in treating multiple myeloma and their impact on patient-reported outcomes. This study will collect information that is already in medical records regarding treatment and diagnostic procedures. Patients are asked to complete questionnaires for …

line of therapy
immunomodulatory imide drug
proteasome inhibitor
Local Institute
 (118.1 away) Contact site
  • 22 Jan, 2021
  • +75 other locations
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

As safety information pertaining to the long-term use of HU remains incomplete in spite of the first safety study (ESCORT-HU), an extension of the latter is proposed. ESCORT-HU Extension study aims at evaluating the long-term safety of Siklos focusing on some questions regarding its safety when used in current practice …

Meaux Hospital Center Adults
 (0.9 away) Contact site
  • 30 Jan, 2021
  • +76 other locations
Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

This study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).

lymphoid leukemia
chronic lymphocytic leukemia
Ghef Ch de Meaux /Id# 207002
 (0.9 away) Contact site
  • 26 Jan, 2021
  • +77 other locations